Obesity is not going anywhere whether ozempic exists or doesnt. People will still have obesity and that seems to lead to excess CSF production with increase ICP and pushes on the back of the eyes creating papilledema. Don't get me wrong my main concern is with managements capability and Alex Sinclair deleting her twitter.
Also with the too stringent diagnostic criteria leading to low patient uptake in the trials. But the drug itself is the only one I have seen that has promising data wrt icp reduction.
Obesity is not going anywhere whether ozempic exists or doesnt....
Add IXC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $5.411M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 158 | 7.4¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 8.0¢ | 5000 | 1 |
View Market Depth
| Last trade - 16.12pm 29/07/2024 (20 minute delay) ? |
| IXC (ASX) Chart |
Day chart unavailable